After Hours Summary: SGH +10%, CTAS +3%, CCIH -14%, AIR -9%, CAMP -4%, NKE -1.2% on earnings/guidance, LJPC +13% on Giapreza approval and CELG -4% on REVLIMID updateAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: SGH +9.6%, CTAS +2.7%
Companies trading higher in after hours in reaction to news: NXTD +17.7% and BVSN +12.5%(continued strength), LJPC +13.1% (FDA has approved Giapreza (angiotensin II) to increase blood pressure in adults with septic or other distributive shock; to host call at 8:30 am ET on December 22), INVE +7% (closes privately placed stock purchase transaction for sale of $20 mln of preferred stock to First Eagle Investment Management), VTVT +5.4% (entered into a global licensing agreement with Reneo Pharmaceuticals), GSUM +4.7% (still checking), COUP +2.3% (light volume; initiated with Outperform at Oppenheimer), FH +2.1% (after closing near highs -- up +38%), WMC +1.3% (reauthorizes its share repurchase program, permitting the repurchase of up to 2,100,000 shares of its common stock through December 31, 2019)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: CCIH -13.6%, AIR -8.8%, CAMP -3.9%, NKE -1.2%
Companies trading lower in after hours in reaction to news: CELG -4% (Celgene and LYSARC provide update on Phase III ‘RELEVANCE' study of REVLIMID; did not achieve superiority in the co-primary endpoints), WWE -3.4% (CEO sold 3,340,000 shares in a block trade on Dec 21), DPW -3.1% (continued weakness), FL -1% (following NKE results)
